X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Pharmaceuticals

期刊標題檢索 PHARMACEUTICALS 最新評論: Intentionally logged in to write some comments for everyone's referenc... (2024-06-13)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Pharmaceuticals]您好,您是該頁面的第 62825 位訪客。

期刊簡介
期刊名稱Pharmaceuticals Pharmaceuticals
LetPub Score
7.0
50 ratings
Rate

Reputation
8.0

Influence
5.8

Speed
9.6

期刊簡稱PHARMACEUTICALS-BASE
ISSN1424-8247
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.100.8450.977
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q256 / 183
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Drug Discovery
Q265 / 157
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine
Q284 / 178

自引率 (2023-2024)4.70%自引率趨勢
掲載範囲
Pharmaceuticals (ISSN 1424-8247) is an international scientific journal of medicinal chemistry and related drug sciences.
官方網站https://www.mdpi.com/journal/pharmaceuticals
在線稿件提交
開放訪問Yes
出版商Multidisciplinary Digital Publishing Institute (MDPI)
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區SWITZERLAND
發行頻率
創刊年0
每年文章數1704每年文章數趨勢
黃金OA百分比99.70%
OA Related Info
APC: Yes( CHF2900; )
APC waiver:Check Notes
Other charges: No
Keywords: drugs
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CHEMISTRY, MEDICINALSCIEQ220/72
PHARMACOLOGY & PHARMACYSCIEQ169/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1424-8247%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 6 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Pharmaceuticals】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Asian Journal of Pharmaceutical SciencesH-index: 27

    CiteScore: 18.30
    Bioengineering & Translational MedicineH-index: 0

    CiteScore: 8.40
    Journal of Pharmaceutical InvestigationH-index: 0

    CiteScore: 10.20
    PharmaceuticsH-index: 32

    CiteScore: 7.90
    Cancer NanotechnologyH-index: 0

    CiteScore: 5.20
    Advanced TherapeuticsH-index: 0

    CiteScore: 7.10
    SCIENTIA PHARMACEUTICAH-index: 0

    CiteScore: 4.60
    BioImpactsH-index: 0

    CiteScore: 4.80
    Drug Metabolism LettersH-index: 0

    CiteScore: 2.80
    Recent Patents on Drug Delivery and FormulationH-index: 0

    CiteScore: 2.30
    學科內最受檢索的期刊 頁面查看次數
    Pharmaceutics120053
    Asian Journal of Pharmaceutical Sciences56381
    Bioengineering & Translational Medicine33021
    Advanced Therapeutics26080
    Cancer Nanotechnology12723
    BioImpacts6959
    International Journal of Pharmaceutics: X3279
    Journal of Pharmaceutical Investigation3228
    Recent Patents on Drug Delivery and Formulation2796
    Drug Metabolism Letters2668
  •  

    Pharmaceuticals Pharmaceuticals
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Pharmaceuticals] 的評論撰寫評論
作者: lisunrise


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-06-13 13:49:23 評論於
Intentionally logged in to write some comments for everyone's reference. 
I have submitted two articles (related to pharmacy) to this journal in the past year, both to the same special issue. 
The journal editors are responsible and serious (the two submissions were handled by two different editors), and they usually respond within 1-2 days, sometimes even urging the authors to speed up :)
The review speed is about one month, very fast. 
Both of my articles were accepted within a little over a month from submission, no more than two months. 
At each stage of the process, there are different editors contacting you, each editor responds quickly, is responsible and very professional. 
Thumbs up to this journal!
(0) 讚! | lisunrise

作者: Regulus


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2021-10-28 08:42:33 評論於
Based on your research direction, it seems to be related to medical institutions, right? It has been widely reported that Chinese hospitals have frequently engaged in academic misconduct, and MDPI automatically rejects articles from Chinese hospitals. I have also encountered cases where reviewers agreed to publish my work but it was ultimately rejected by the editor with weak justifications.
(3) 讚! | Regulus

作者: TVT


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2021-10-12 18:57:13 評論於
I totally agree with the original poster, try to avoid submitting to MDPI journals, everyone understands what's going on.
(0) 讚! | TVT

作者: TVT


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2021-10-12 18:55:38 評論於
I fully agree, it is best to avoid submitting articles to MDPI journals, as everyone understands what is going on.
(5) 讚! | TVT

作者: cannab


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-20 03:51:44 評論於
Everyone, don't submit it! This magazine is a joke! The magazine had a special issue, and I received an invitation from the special issue editor because I had published several papers in the relevant field. Since I was not familiar with the magazine, I specifically emailed to inquire and sent the title and abstract of the article to the special issue editor. The response from the editor was very suitable, so I decided to write and submit the article to the magazine. The special issue editor is an Italian professor in the same field. Due to the deadline being before Christmas, and our work being particularly busy during this period, everyone worked overtime and made the necessary revisions to the article, submitting it nearly a week in advance. On January 3rd, I received a rejection letter, without any review comments, just casually stating that the manuscript will not be processed and advised to submit to another journal. I suspect that they did not even review the submission. I emailed the editor to inquire about the review comments, but there was no reply. It is evident that this journal is extremely careless and irresponsible in handling submissions. I suggest that everyone boycott such journals.
(26) 讚! | cannab

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Pharmaceuticals] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*